Ballicules.com

Entacapone

COMTAN

What it isCOMT inhibitor blocking peripheral levodopa breakdown; Parkinson disease with wearing-off.

Why this oneUnlike tolcapone it stays peripheral and avoids liver monitoring; unlike opicapone it accompanies each levodopa dose.

What limits itIt is useless without levodopa. Diarrhea can end treatment, while orange urine discoloration is harmless.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Parkinson's disease — adjunct to levodopa/carbidopaadult200 mg with each levodopa/carbidopa dose200 mg with each levodopa/carbidopa dose8 doses/day (1,600 mg/day)

Renal Undefined

Hepatic Caution — entacapone AUC and Cmax approximately doubled in documented liver disease

Limited clinical experience with daily doses above 1,600 mg.

Instructions

Cautions

Adverse reactions

Pregnancy Category C — fetal variations and eye anomalies in animal studies; use only if potential benefit justifies fetal risk.

Lactation Excreted in rat milk; unknown in humans — use caution.

NO BOXED WARNINGS

Principal riskUseless alone; must accompany every levodopa dose

Cost, est. cash$10–$500/month

Generic entry2012

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability1 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityOrthostasis, hallucinations, dyskinesia and impulse-control symptoms; abrupt withdrawal can be hazardous.

Mechanism of action: Entacapone ballicule

Entacapone ballicule: receptor binding, kinetics and half-life diagram

Open Entacapone in the interactive console ↗

Memory aids: mascots and interaction avatars

Entacapone COMTAN mascot mnemonic cartoon
“Compton into Capone”
Entacapone no kinetic interactions avatar
no kinetic interactions

Open Entacapone in the interactive console ↗